As of 2024-09-12, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 23.8x | 18.7x |
| Forward P/E multiples | 20.4x - 25.3x | 23.9x |
| Fair Price | (3.87) - (4.83) | (4.13) |
| Upside | -112.4% - -115.5% | -113.2% |
| Date | EV/EBITDA |